-
公开(公告)号:US11001603B2
公开(公告)日:2021-05-11
申请号:US17009590
申请日:2020-09-01
发明人: Laurent Pierre Paul Debien , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ul Sharif
IPC分类号: A01N43/04 , A61K31/70 , C07H19/23 , A61K31/7076 , C07H19/16 , C07H19/20 , C07H19/207 , C07F9/6561 , C07H19/04 , A61K31/706 , A61K45/06 , A61K31/7052 , A61K31/7064 , C07H19/14
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US11667662B2
公开(公告)日:2023-06-06
申请号:US17206896
申请日:2021-03-19
发明人: Laurent Pierre Paul Debien , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ui Sharif
IPC分类号: A01N43/04 , A61K31/70 , C07H19/23 , A61K31/7076 , C07H19/16 , C07H19/20 , C07H19/207 , C07F9/6561 , C07H19/04 , A61K31/706 , A61K45/06 , A61K31/7052 , A61K31/7064 , C07H19/14
CPC分类号: C07H19/23 , A61K31/70 , A61K31/706 , A61K31/7052 , A61K31/7064 , A61K31/7076 , A61K45/06 , C07F9/6561 , C07F9/65616 , C07H19/04 , C07H19/14 , C07H19/16 , C07H19/20 , C07H19/207 , A61K31/7076 , A61K2300/00 , A61K31/7064 , A61K2300/00 , A61K31/706 , A61K2300/00
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US11058704B2
公开(公告)日:2021-07-13
申请号:US16338975
申请日:2017-10-02
发明人: Laurent Pierre Paul Debien , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ul Sharif
IPC分类号: A01N43/04 , A61K31/70 , A61K31/7076 , A61K31/706 , A61K31/7064 , A61K39/395 , C07H19/20 , C07H19/207 , C07H19/23
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US10239912B2
公开(公告)日:2019-03-26
申请号:US15400748
申请日:2017-01-06
发明人: Laurent Pierre Paul Debien , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ul Sharif
IPC分类号: A61K31/70 , A01N43/04 , C07H19/23 , A61K31/7052 , A61K31/7076 , C07H19/16 , C07H19/20 , C07H19/207 , A61K31/7064 , C07H19/14 , C07F9/6561 , C07H19/04
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US20240352057A1
公开(公告)日:2024-10-24
申请号:US18516459
申请日:2023-11-21
发明人: Laurent Pierre Paul DEBIEN , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ui Sharif
IPC分类号: C07H19/23 , A61K31/70 , A61K31/7052 , A61K31/706 , A61K31/7064 , A61K31/7076 , A61K45/06 , C07F9/6561 , C07H19/04 , C07H19/14 , C07H19/16 , C07H19/20 , C07H19/207
CPC分类号: C07H19/23 , A61K31/70 , A61K31/7052 , A61K31/706 , A61K31/7064 , A61K31/7076 , A61K45/06 , C07F9/6561 , C07F9/65616 , C07H19/04 , C07H19/14 , C07H19/16 , C07H19/20 , C07H19/207
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US10981944B2
公开(公告)日:2021-04-20
申请号:US16273843
申请日:2019-02-12
发明人: Laurent Pierre Paul Debien , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ul Sharif
IPC分类号: A01N43/04 , A61K31/70 , C07H19/23 , A61K31/7076 , C07H19/16 , C07H19/20 , C07H19/207 , C07F9/6561 , C07H19/04 , A61K31/706 , A61K45/06 , A61K31/7052 , A61K31/7064 , C07H19/14
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US20240285665A1
公开(公告)日:2024-08-29
申请号:US18629820
申请日:2024-04-08
发明人: Laurent Pierre Paul DEBIEN , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan UI Sharif
IPC分类号: A61K31/7076 , A61K31/706 , A61K31/7064 , A61K39/395 , C07H19/20 , C07H19/207 , C07H19/23
CPC分类号: A61K31/7076 , A61K31/706 , A61K31/7064 , A61K39/3955 , C07H19/20 , C07H19/207 , C07H19/23
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US11267845B2
公开(公告)日:2022-03-08
申请号:US16461649
申请日:2017-11-17
发明人: Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Ehesan Ul Sharif
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
公开(公告)号:US20190309010A1
公开(公告)日:2019-10-10
申请号:US16273843
申请日:2019-02-12
发明人: Laurent Pierre Paul DEBIEN , Juan Carlos Jaen , Jaroslaw Kalisiak , Kenneth V. Lawson , Manmohan Reddy Leleti , Erick Allen Lindsey , Dillon Harding Miles , Eric Newcomb , Jay Patrick Powers , Brandon Reid Rosen , Ehesan Ul Sharif
IPC分类号: C07H19/23 , A61K31/706 , A61K45/06 , C07H19/207 , C07H19/20 , C07H19/16 , A61K31/7076 , A61K31/70 , C07F9/6561 , C07H19/14 , A61K31/7064 , A61K31/7052 , C07H19/04
摘要: Compounds that modulate the conversion of AMP to adenosine by 5′-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.
-
-
-
-
-
-
-
-